Cole Schmidtknecht expected to pay $66.86 for a three-month supply of his preventative asthma inhalers in January 2024 when he went to his Walgreens pharmacy in Appleton, Wisconsin. The pharmacy ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

Are you a print subscriber? Activate your account. By Ad Age Staff - 2 hours 11 min ago By Ad Age and Creativity Staff - 2 hours 28 min ago By Jack Neff - 3 hours 14 min ago 4 hours 25 min ago 6 ...

Since its online debut late last month, the one-minute ad pitching the company’s legal knockoff of the weight-loss drug Wegovy has stoked the controversy over the high costs of a new generation ...

COPENHAGEN--Novo Nordisk will launch its hugely popular anti-obesity drug Wegovy in Japan on Feb. 22 next year, its first launch in Asia, the company said on Thursday, even as it struggles to keep ...

The Supreme Court, on Monday, dismissed an appeal that Governor Siminalaye Fubara filed to challenge the Court of Appeal judgement that affirmed Hon. Martin Amaewhule as the authentic Speaker of ...

Within Novo Nordisk's comprehensive business update to investors, attention latched onto early data for an oral obesity therapy that outperformed the company’s big-selling GLP-1 agonist Wegovy ...

They told him there were no cheaper alternatives or generic medications available, they didn't contact OptumRx to request an exception on Cole's behalf, and they didn't ask Cole's doctor to request an ...

In the other healthcare-related ad, online prescription provider Hims & Hers stirred up controversy with a commercial for its GLP-1, which is a knock-off of the weight-loss drug Wegovy, according to a ...

The couple is also suing Walgreens.